Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen

Neurochemistry International

Volumn 38, Issue 1, 2001, Pages 31-42

  Hillefors, Mi ^a   Von Euler, Gabriel ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

7 OH DPAT; Bromocriptine; Caudate putamen; Clozapine; Dopamine D3 receptor; Haloperidol; Receptor binding

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; BROMOCRIPTINE; CLOZAPINE; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; IODINE 125; QUINPIROLE; RACLOPRIDE; REMOXIPRIDE; SULPIRIDE; TRITIUM; (5,6 DIMETHOXYINDAN 2 YL)DIPROPYLAMINE; (5,6-DIMETHOXYINDAN-2-YL)DIPROPYLAMINE; 1,3 DITOLYLGUANIDINE; 1,3-DITOLYLGUANIDINE; 2 DIPROPYLAMINO 1,2,3,4 TETRAHYDRO 6 (4 METHOXYPHENYLSULFONYLMETHYL)NAPHTHALENE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H (1)BENZOPYRANO(4,3 B) 1,4 OXAZIN 9 OL; 3,4,4A,10B-TETRAHYDRO-4-PROPYL-2H,5H-(1)BENZOPYRANO(4,3-B)-1,4-OXAZIN-9-OL; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; BENZOPYRAN DERIVATIVE; DOPAMINE; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, RAT; DRUG DERIVATIVE; GUANIDINE DERIVATIVE; GUANOSINE TRIPHOSPHATE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; INDAN DERIVATIVE; IODOSULPRIDE; MAGNESIUM; OXAZINE DERIVATIVE; SODIUM; SULFONE; TETRALIN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; ANIMAL; BINDING COMPETITION; DRUG EFFECT; GERMFREE ANIMAL; KINETICS; METABOLISM; PROTEIN BINDING; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BENZOPYRANS; BINDING, COMPETITIVE; CAUDATE NUCLEUS; CLOZAPINE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; GUANIDINES; GUANOSINE TRIPHOSPHATE; HALOPERIDOL; HETEROTRIMERIC GTP-BINDING PROTEINS; INDANS; KINETICS; MAGNESIUM; MALE; OXAZINES; PROTEIN BINDING; PUTAMEN; QUINPIROLE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REMOXIPRIDE; SODIUM; SPECIFIC PATHOGEN-FREE ORGANISMS; SULFONES; SULPIRIDE; TETRAHYDRONAPHTHALENES;

EID: 0034747210     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(00)00047-4     Document Type: Article

References (44)

1. 3 receptor agonist ligand, to CHO-K1 cells. Life Sci. 57:1995;1401-1410.
2. 3 subtypes. Brain Res. 649:1994;95-110.
3. 3 receptors. Eur. J. Pharmacol. 239:1993;269-270.
4. 3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study. Neuropsychopharmacol. 18:1998;305-316.
5. 3 dopamine receptor: pharmacological properties and development of antibodies. J. Pharmacol. Exp. Ther. 264:1993;1002-1011.
6. 2 receptor mRNA. Brain Res. 564:1991;203-219.
7. 3 receptors in rat olfactory tubercle. J. Pharmacol. Exp. Ther. 268:1994;935-942.
8. 3 dopamine receptors to G proteins. FEBS Lett. 315:1993;223-226.
9. Dohlman H.G., Thorner J., Caron M.G., Lefkowitz R.J. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:1991;653-688.
10. 3 dopamine receptor generated by alternative splicing in the third cytoplasmatic loop. J. Biol. Chem. 268:1993;5872-5878.
11. 3 dopamine receptor ligand. J. Med. Chem. 36:1993;1499-1500.
12. 3 receptors in rat brain. Eur. J. Pharmacol. 211:1992;189-194.
13. 3 dopamine receptor produced through various patterns of alternative splicing. Biochem. Biophys. Res. Comm. 176:1991;1584-1592.
14. 3H -dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. Life Sci. 30:1982;1587-1595.
15. Hedlund P., von Euler G. EasyBound - a user-friendly approach to nonlinear regression analysis of binding data. Comp. Meth. Progr. Biomed. 58:1999;245-249.
16. 3H ]PD 128907 in the caudate-putamen of the adult rat. Brain Res. 822:1999;126-131.
17. 3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography. Eur. J. Pharmacol. 261:1994;179-183.
18. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., Tang C., Shen Q., Salon J.A., Morse K., Laz T., Smith K.E., Nagarathnam D., Noble S.A., Branchek T.A., Gerald C. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature. 396:1998;674-679.
19. 125I ]trans-7-OH-PIPAT-A. Eur. J. Pharmacol. 235:1993;165-166.
20. 125I ]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;611-617.
21. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol. Rev. 49:1997;231-252.
22. 3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264:1993;991-1001.
23. 3H ]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci., U.S.A. 89:1992;8155-8159.
24. 3 receptor binding by N-ethylmaleimide and neurotensin. Brain Res. 643:1994;343-348.
25. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. 3 receptor expressed in transfected cell lines. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 266:1994;79-85.
27. 3 receptors. Mol. Pharmacol. 43:1993;749-754.
28. 2 dopamine receptor expressed in CHO cells. FEBS Lett. 324:1993;81-86.
29. 3 receptor mRNAs in human and rat brain. Neurochem. Int. 20:(Suppl.):1992;33S-43S.
30. 3 receptor. Bioorg. Med. Chem. Lett. 6:1996;403-408.
31. 3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem. Biophys. Res. Comm. 194:1993;368-374.
32. 3 receptor gene giving rise to an mRNA isoform expressed in rat brain. Biochem. Biophys. Res. Comm. 194:1993;465-471.
33. 3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275:1995;1355-1366.
34. Reader T., Dewar K. Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease. Neurochem. Int. 34:1999;1-21.
35. 3 receptor in the rat cerebellar cortex: a light microscope autoradiographic study. Neurosci. Lett. 190:1995;163-166.
36. 3 receptors in vivo. Eur. J. Pharmacol. 218:1992;373-375.
37. 3 receptor coexistence. Brain Res. Rev. 26:1998;236-242.
38. 1 pituitary cells. FEBS Lett. 312:1992;123-126.
39. 2 receptor. Eur. J. Pharmacol. 225:1992;331-337.
40. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
41. 3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 779:1998;58-74.
42. 3H ]propyl-2-aminotetralin and carbetapentane. J. Neurochem. 64:1995;700-710.
43. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J. Neural Transm. [GenSect]. 94:1993;11-19.
44. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord S.M., Marshall F.H. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature. 396:1998;679-682.